Nasdaq biol.

LAKE FOREST, Calif., Sept. 13, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten ...BIOLASE, Inc. (BIOL.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock BIOLASE, Inc. | Nasdaq: BIOL | Nasdaq./PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has been invited to present at the Spring Into Action...

BIOL Biolase Inc Statement of Ownership (sc 13g) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No ...FOOTHILL RANCH, Calif., May 13, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for its first quarter ended March 31, 2021.BIOL. The Nasdaq Stock Market LLC. (Nasdaq Capital Market). Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 ...

LAKE FOREST, Calif., March 17, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the fourth quarter and full year ...BIOLASE, Inc. (NASDAQ:BIOL) fell 43.3% to $1.85 in pre-market trading after the company announced pricing of $4.5 million underwritten public offering of Series J convertible redeemable preferred ...

Biolase (NASDAQ: BIOL) stock is taking a beating on Friday following the release of its earnings report for the first quarter of 2023. The bad news for investors in BIOL stock is the company’s ...P/E & PEG Ratios. Data is delayed at least 15 minutes. Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the ...LAKE FOREST, Calif., July 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release second quarter 2022 financial and operating results on Thursday, August 11, 2022 after the close of the U.S. financial markets and will host a conference call and webcast that day …2 analysts have issued 1-year price objectives for BIOLASE's shares. Their BIOL share price targets range from $4.00 to $150.00. On average, they anticipate the company's stock price to reach $77.00 in the next year. This suggests a possible upside of 6,900.0% from the stock's current price.

Biolase Inc (NASDAQ:BIOL) is the most popular stock in this table. On the other hand Gyrodyne, LLC (NASDAQ:GYRO) is the least popular one with only 1 bullish hedge fund positions. Just Energy ...

About · Highlight. A world's leading dental laser company. Industry · Exchange. NASDAQ · Listing Date. 11/12/1992 · Established Date · Full-time Employees.

Dental technology company Sonendo ( NYSE: SONX) on Wednesday said its unit PIPStek had filed a patent infringement lawsuit against maker of dental lasers Biolase ( NASDAQ: BIOL ). The lawsuit was ...17 Nov, 2020, 09:00 ET. IRVINE, Calif., Nov. 17, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, completed its leadership council meeting of the Waterlase ...Feb 6, 2021 · IRVINE, Calif., Feb. 5, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has entered into an underwriting agreement with Maxim Group ... These institutions hold a total of 1 shares. Largest shareholders include Huntington National Bank . Biolase Inc (NASDAQ:BIOL) institutional ownership structure ...BIOLASE, Inc. 17 Nov, 2021, 16:05 ET. FOOTHILL RANCH, Calif., Nov. 17, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, encourages stockholders to vote TODAY ...Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific ...

Nelly Dodson. December 4, 2023. Technologies. Biolase Inc (NASDAQ:BIOL) has a beta value of 1.20 and has seen 1.07 million shares traded in the recent trading session. The company, currently valued at $3.29M, closed the recent trade at $1.43 per share which meant it gained $0.28 on the day or 24.35% during that session.At just 47 cents a share, BIOL stock is in danger of being delisted by the Nasdaq, which requires companies to maintain a minimum share price of $1 to remain on the exchange. However, in a news ...FOOTHILL RANCH, Calif., Feb. 1, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, encourages stockholders to vote their shares with respect to the adjourned ...Hedge fund interest in ENGlobal Corp (NASDAQ: ENG) shares was flat at the end of last quarter. This is usually a negative indicator. Our calculations also showed that ENG isn't among the 30 most ...8 Nov 2023 ... (NASDAQ: BIOL), the global leader in dental lasers, today announced groundbreaking findings from a 12-month follow-up to a clinical trial ...

14 Sept 2023 ... Shares in BIOLASE Inc (NASDAQ:BIOL) fell to all time lows; falling 39.57% or 1.29 to 1.97. The CBOE Volatility Index, which measures the implied .../PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it will be presenting at the Benchmark Company Discovery...

Apr 28, 2022 · The Nasdaq Capital Market requires, among other things, that a listing a company's common stock maintain a minimum bid price of at least $1.00 per share. Information for BIOLASE Stockholders BIOLASE, Inc. (BIOL.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock BIOLASE, Inc. | Nasdaq: BIOL | Nasdaq.Biolase (NASDAQ: BIOL) stock is surging more than 26% with heavy trading this morning. Biodexa Pharmaceuticals (NASDAQ: BDRX) shares are gaining over 19% as a prospectus goes into effect.BIOLASE, Inc. (NASDAQ:BIOL) posted its quarterly earnings data on Wednesday, November, 10th. The medical technology company reported ($50.00) earnings per share for the quarter, topping analysts' consensus estimates of ($75.00) by $25.00. The medical technology company had revenue of $9.53 million for the quarter. Real time Biolase (BIOL) stock price quote, stock graph, news & analysis. LAKE FOREST, Calif., Jan. 10, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten ...3 Oct 2023 ... Math. Biol. Neurosci. ISSN 2052-2541. Editorial Office: [email protected]. Copyright ©2023 CMBN.FOOTHILL RANCH, Calif., April 20, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, and EdgeEndo, a global leader in commercializing endodontic products ...

LAKE FOREST, Calif., June 14, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that President and Chief Executive Officer, John Beaver and ...

BIOLASE, Inc. (NASDAQ:NASDAQ:BIOL) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ETCompany ParticipantsTodd Kehrli - Investor Relations, EVC...

LAKE FOREST, Calif., Feb. 9, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that the Company has been awarded a Top Workplaces 2022 honor by the Inland News Group. This award is in addition to the Top Workplaces 2022 honor from the Orange County Register, which …P/E & PEG Ratios. Data is delayed at least 15 minutes. Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the ...According to the recent notification letter, the staff of NASDAQ has determined that for the last ten consecutive business days, from January 21, 2021 to February 3, 2021, the closing bid price of ...Dec 1, 2023 · Short selling BIOL is an investing strategy that aims to generate trading profit from BIOLASE as its price is falling. BIOL shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.Nasdaq News: This is the News-site for the company Nasdaq on Markets Insider Indices Commodities Currencies StocksPosted by Techdows on Nov 30th, 2023. StockNews.com lowered shares of BIOLASE ( NASDAQ:BIOL – Free Report) from a hold rating to a sell rating in a report issued on Wednesday. Separately, Benchmark cut their price objective on shares of BIOLASE from $10.00 to $4.00 in a research report on Wednesday, September 20th. Get BIOLASE alerts:Find the latest SEC Filings data for Biolase, Inc. Common Stock (BIOL) at Nasdaq.com. BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced that its Board of Directors declared a dividend of one one-thousandth of a share of ...BIOL / Biolase Inc (NASDAQ) - Forecast, Price Target, Estimates, Predictions.

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the third quarter ended September 30, 2023. BIOLASE, Inc.(NASDAQ: BIOL), the global ...Research BIOLASE's (Nasdaq:BIOL) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. Dashboard Markets Discover Watchlist Portfolios ScreenerBio-Rad Laboratories, Inc. Class A Common Stock (BIO) Stock Price, Quote, News & History | Nasdaq. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p ...Instagram:https://instagram. best app forex tradingporsche targa gtswhat is the shadow banking systemtop gainers today stocks LAKE FOREST, Calif., June 6, 2022 /PRNewswire/ -- To further accelerate the adoption of lasers as the gold standard of care in dentistry, BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental ...H.C. Wainwright initiated coverage on Korro Bio Inc (NASDAQ: KRRO), a biotech company developing genetic medicines focused … td ameritrade metatraderbest portfolio management BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release second quarter 2023 financial and operating results on Thursday, August 10, 2023, after the ... pet insurance stocks Shares in BIOLASE Inc (NASDAQ: BIOL) fell to all time lows; falling 39.57% or 1.29 to 1.97. The CBOE Volatility Index , which measures the implied volatility of S&P 500 options, was down 4.97% to ...BIOL- running earnings 8/10 LONG BIOL had a triple top in late July so this is a logical long target at 8,0, With earnings in less than two days, volumes above the mean in the past couple of days and a decent price-volume product trend coupled with a Price Monetum Oscillator without any signs of topping out in a momentum stall BIOL had a triple top in late July so this is a logical long target ...